Earnings call transcript: Oxford Square Capital misses Q1 2026 estimates

Oxford Square Capital’s Q1 2026 results missed expectations, with EPS of $0.05 versus $0.07 consensus and revenue of $8.9 million versus $9.99 million expected. Net asset value per share fell 21.9% QoQ to $1.32, while investment losses widened to $29.7 million from $18.3 million. Shares dropped 3.87% pre-market, though the company maintained monthly distributions of $0.035 per share and highlighted new AI investments in Invisible Technologies and Constellation.

Analysis

OXSQ is not just an earnings miss; it is a balance-sheet impairment story masquerading as a dividend yield story. The key second-order issue is that a lower NAV mechanically raises the payout burden as a percentage of remaining equity, so each quarter of mark-to-market damage makes the distribution look more generous while actually becoming less sustainable. That dynamic usually compresses the equity multiple first, then forces either asset sales, slower originations, or a reset in the payout once credit marks lag the broader loan market.

The operating backdrop is still deteriorating in a way that matters for middle-market credit investors: weaker loan prices, higher defaults, and rising distress ratios tend to show up first in equity marks, then in cash income, and finally in realized losses over the next 2-3 quarters. OXSQ’s AI tilt is directionally interesting but too small to offset portfolio-wide spread compression unless it can source genuinely differentiated equity-like outcomes; otherwise, it just adds venture-style mark volatility to an already levered credit book. That makes the AI narrative more of a volatility driver than a near-term fundamental fix.

For GS, the read-through is modestly negative only insofar as this reinforces a softer private-credit / leveraged-loan risk tone, which can keep financing and syndication conditions tighter at the margin. The market is probably underpricing the probability that the current distribution is defended for optics even as NAV erosion accelerates, which can set up an eventual harsher reprice. The cleanest contrarian point is that the stock may already be discounting distress, but a high yield is not a catalyst if the numerator is being eaten by recurring loss marks.

Key Decisions for Investors

• Short OXSQ common for 1-3 months on any post-print bounce; risk/reward favors a drift lower as NAV erosion and distribution skepticism widen the discount to book. Use a tight stop above the pre-earnings gap-fill area because the stock can squeeze on yield-seeking flows.
• Pair trade: long GS / short OXSQ for 1-2 quarters. The idea is to express lower-quality credit stress via the BDC while staying neutral-to-bullish on higher-quality trading and asset-management franchises that can benefit from volatility. Favor this if leveraged loan weakness persists.
• Buy OXSQ put spreads 2-4 months out rather than outright puts. The catalyst path is slow: another weak quarter, possible NAV compression, and eventual payout questions. Spreads cap premium bleed while still capturing a further 15-25% downside move.
• If seeking income exposure, rotate from OXSQ into stronger BDCs with better NAV stability and lower payout coverage risk over the next 1-2 quarters. The relative-value trade is toward names with lower leverage and less mark-to-market sensitivity.
• Watch for a tactical long only if management signals a dividend reset or equity issuance slowdown. Until then, the risk/reward on the long side is poor because the market is likely to treat every new AI investment as incremental risk, not a near-term value creator.